Financhill
Sell
40

MAQAF Quote, Financials, Valuation and Earnings

Last price:
$3.24
Seasonality move :
0.53%
Day range:
$3.24 - $3.24
52-week range:
$2.69 - $3.60
Dividend yield:
0%
P/E ratio:
30.75x
P/S ratio:
47.18x
P/B ratio:
2.44x
Volume:
--
Avg. volume:
403
1-year change:
7.1%
Market cap:
$4.7B
Revenue:
$96.2M
EPS (TTM):
$0.11

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Atlas Arteria Ltd. has -- downside to fair value with a price target of -- per share.

MAQAF vs. S&P 500

  • Over the past 5 trading days, Atlas Arteria Ltd. has overperformed the S&P 500 by 0.63% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Atlas Arteria Ltd. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Atlas Arteria Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Atlas Arteria Ltd. reported revenues of --.

Earnings Growth

  • Atlas Arteria Ltd. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Atlas Arteria Ltd. reported earnings per share of --.
Enterprise value:
7.8B
EV / Invested capital:
--
Price / LTM sales:
47.18x
EV / EBIT:
32.04x
EV / Revenue:
82.45x
PEG ratio (5yr expected):
1.00x
EV / Free cash flow:
--
Price / Operating cash flow:
9.77x
Enterprise value / EBITDA:
26.95x
Gross Profit (TTM):
$16.6M
Return On Assets:
4.15%
Net Income Margin (TTM):
--
Return On Equity:
5.38%
Return On Invested Capital:
4.21%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2011-12-31 2012-12-31 2013-12-31 2012-12-31 2013-12-31
Income Statement
Revenue $90.7M $91.8M -- $93.3K $214.3K
Gross Profit $90.7M $86.4M -- $93.3K $214.3K
Operating Income -$54.6M $895.1K -$32.1M -$51.6M $45.3M
EBITDA -$179.2M -$8.9M -$32.1M -$51.6M $45.3M
Diluted EPS -$0.60 -$0.25 $2.67 -$0.10 $0.01
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Balance Sheet
Current Assets $152.3M $142.1M $118.9M $182.1M --
Total Assets $3.9B $3.5B $5.5B $5.3B --
Current Liabilities $76.8M $76.4M $80.6M $80.5M --
Total Liabilities $1.2B $1.2B $1.2B $1.2B --
Total Equity $2.6B $2.3B $4.3B $4.1B --
Total Debt $1.2B -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2011-06-30 2012-06-30 2013-06-30 2012-06-30 2013-06-30
Cash Flow Statement
Cash Flow Operations -- -- -- -- --
Cash From Investing -$3.4M -$2.3M -$63.8M -$1.1M -$65.9M
Cash From Financing -$58.5M -$47M -$41.6M -$23.2M -$10.7M
Free Cash Flow -- -- -- -- --
MAQAF
Sector
Market Cap
$4.7B
$487.5M
Price % of 52-Week High
89.86%
80%
Dividend Yield
0%
0%
Shareholder Yield
--
1.52%
1-Year Price Total Return
7.1%
--
Beta (5-Year)
0.539
0.551
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
-246.26%
Growth streak:
1 years

Technicals

8-day SMA
Sell
Level $3.24
200-day SMA
Sell
Level $3.39
Bollinger Bands (100)
Sell
Level 3.07 - 3.59
Chaikin Money Flow
Sell
Level -3.2K
20-day SMA
Buy
Level $3.23
Relative Strength Index (RSI14)
Buy
Level 57.83
ADX Line
Buy
Level 39.39
Williams %R
Sell
Level 0
50-day SMA
Buy
Level $3.15
MACD (12, 26)
Buy
Level 0.02
25-day Aroon Oscillator
Buy
Level 12
On Balance Volume
Neutral
Level 12.7K

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.7944)
Buy
CA Score (Annual)
Level (0.7693)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-1.7227)
Buy
Piotroski F Score (Annual)
Level (7)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Atlas Arteria Ltd. owns, operates, and develops toll roads globally. The firm's projects include toll roads, bridges, tunnels, and investment in entities in the same industry sector. It operates through the following segments: APRR, ADELAC, Warnow Tunnel, Chicago Skyway, and Dulles Greenway. The company was founded on December 16, 2009 and is headquartered in Melbourne, Australia.

Stock Forecast FAQ

In the current month, MAQAF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MAQAF average analyst price target in the past 3 months is --.

  • Where Will Atlas Arteria Ltd. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Atlas Arteria Ltd. share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Atlas Arteria Ltd.?

    Analysts are divided on their view about Atlas Arteria Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Atlas Arteria Ltd. is a Sell and believe this share price will rise from its current level to --.

  • What Is Atlas Arteria Ltd.'s Price Target?

    The price target for Atlas Arteria Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is MAQAF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Atlas Arteria Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of MAQAF?

    You can purchase shares of Atlas Arteria Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Atlas Arteria Ltd. shares.

  • What Is The Atlas Arteria Ltd. Share Price Today?

    Atlas Arteria Ltd. was last trading at $3.24 per share. This represents the most recent stock quote for Atlas Arteria Ltd.. Yesterday, Atlas Arteria Ltd. closed at $3.24 per share.

  • How To Buy Atlas Arteria Ltd. Stock Online?

    In order to purchase Atlas Arteria Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is JetBlue The Best Airline Stock?
Is JetBlue The Best Airline Stock?

Following a general trend of improvement among airline stocks, shares…

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Stock Ideas

Sell
47
Is NVDA Stock a Buy?

Market Cap: $4.3T
P/E Ratio: 60x

Buy
58
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
73
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 39x

Alerts

Buy
80
FEIM alert for Dec 13

Frequency Electronics, Inc. [FEIM] is up 28.76% over the past day.

Buy
57
MOD alert for Dec 13

Modine Manufacturing Co. [MOD] is down 15.32% over the past day.

Sell
42
OKLO alert for Dec 13

Oklo, Inc. [OKLO] is down 14.91% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock